In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Although AbbVie, Eli Lilly ... impact. Michaels noted "penalties in the government channel and with existing contracts in the commercial setting" as barriers to hiking drug prices. However, the ...

Tariffs on pharmaceutical imports could hurt Lilly, especially with its dependence on products made in Ireland. The president ...

One of the more interesting aspects about President Donald Trump's recent tariffs is that ... one of the best pharma stocks to own has been Eli Lilly (NYSE: LLY). But now, an investment in Lilly ...

Many investments Mr. Trump claims credit for predate his return to office or are based on vague future pledges. Here's a fact ...

Eli Lilly CEO Dave Ricks urged the Trump administration to move fast on ... on tariffs or retaliatory tariffs would have a negative impact on not just Lilly but the entire pharmaceutical industry.

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

Ireland has become a major base for US pharma companies, including Pfizer, Eli Lilly and Johnson & Johnson. That’s bolstered the economies of individual towns and played a role in the country’s ...

The president said his executive order will require pharmaceutical companies to price drugs in the U.S. in line with the ...

President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...